Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
LAFAYETTE, La. (AP) — Lafayette General Health's research department is seeking male and female pancreatic cancer patients for an observational study on the impact of chemotherapy on their quality of life.
Survey participants must be 18 or older. The Advocate reports (http://bit.ly/11TyhFO ) the study will evaluate the medications Abraxane and Gemcitabine in patients diagnosed with metastatic adenocarcinoma of the pancreas.
The hospital says the objective of the research is to gather information and assess the quality of life in patients who are newly diagnosed before initiation of first-line chemotherapy, or currently treated with certain medications.
___
Information from: The Advocate, http://theadvocate.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
